}
2022年第18届世界皮肤癌大会(WCCS)
2022年第18届世界皮肤癌大会(WCCS)
上一届会议 | 下一届 没有了

科室:肿瘤

城市:阿根廷-布宜诺斯艾利斯

地点:Centro de Convenciones Buenos Aires

时间:2022-10-26 - 2022-10-29

会议简介

2022年第18届世界皮肤癌大会(WCCS)将于2022年10月26日至29日在布且诺斯艾利斯举行,WCCS 2022 - 18th WORLD CONGRESS ON CANCERS OF THE SKIN. 18th WCCS 2022 is a hybrid event so the participants will be able to select Onsite or Online modality. * Students must submit copy of their student card or a certificate from the Learning Institution as a regular student.代表我们的联合组织者,皮肤癌基金会(美国)、CILAD (伊比利亚拉丁美洲 皮肤病学院)、皮肤癌基金会( 阿根廷)和第 18届世界皮肤癌大会组委会,布宜诺斯艾利斯,混合活动,10 月 26 日至 29 日,在我们最初的计划阶段,我们将活动安排在 2020 年 6 月。因此,我们将庆祝在布宜诺斯艾利斯举行的 1995 年第五届世界皮肤癌大会的“银周年” 。但随之而来的 COVID -19 突然改变了我们 2020 年的预定活动!我们认为,2022 年 10 月是打开我们强加的边界障碍并恢复正常科学活动模式的时候。回顾 1995 年的科学计划,人们可以意识到皮肤癌领域已经取得的巨大进步,并思考我们将继续面临的挑战。我们的目标是通过现场和在线方式在混合大会 上召集对黑色素瘤和非黑色素瘤皮肤癌的基础科学、预防和治疗感兴趣的同事。

大会组委会正在努力确保高跨学科科学标准和友好的环境,以鼓励网络和人际交流。我们将聚在一起学习,学习和享受友谊!布宜诺斯艾利斯市已成为世界主要旅游目的地,一座拥有多元文化遗产和许多友好当地传统的城市。它拥有出色的全球交通连接和实惠的住宿条件。它也是计划会前或会后前往拉丁美洲南部独特风景自然景点的基地!加入我们的布宜诺斯艾利斯,在2022 年 10 月 26 日至 29 日在布宜诺斯艾利斯,现场和在线举行的第 18 届 WCCS 上获得有益的学术和友好体验。


image.png

* 学生必须作为普通学生提交学生证复印件或学习机构出具的证明。

* 居民必须提交其项目主任的来信

** CILAD:伊比利亚拉丁美洲皮肤病学院

** SAD:阿根廷皮肤病学会

*** 国家皮肤病学会(拉丁美洲国家)成员和 Grupo Basileiro de Melanoma 成员。

现场参会注册费用包括

全体国会代表、CILAD 成员和国家红会

l  参加所有大会会议、电子海报、行业会议和技术展览。

l  进入开幕式和闭幕式。

l  入场欢迎酒会。

l  国会文件。

l  出席证明

学生住院医

l  参加所有大会会议、海报区和技术展览。

l  进入开幕式和闭幕式。

l  国会文件。

l  出席证明

2023 1 26 日前可 访问第 18 WCCS 大会数字平台按需完整的科学和教育计划

 

在线方式注册费用包括

l  访问第 18 WCCS 大会数字平台直播完整的科学和教育计划

l  在线互动和讨论的机会

l  直到 2023 1 26 日,所有科学课程都可以在线获取

l  出席证明

会议日程
image.pngMAIN SPEAKERS
Boris C. Bastian
  • Gerson and Barbara Bass Bakar Distinguished Professor in Cancer Research, UCSF

  • Professor of Dermatology and Pathology, University of California, San Francisco

Reinhard Dummer (Germany)
  • Professor of the University of Zurich and Vice-Chairman of the Department of Dermatology in the University Hospital of Zürich, Switzerland and is a key thought leader in worldwide cutaneous oncology. Currently he is heading of the Skin Cancer Unit and the Clinical Trial Unit of the Department of Dermatology.

Claus Garbe (Germany)
  • University Professor of Dermatology at Eberhard Karls University, Germany, where he is also Head of the division of Dermato-oncology.

  • Head of the Interdisciplinary Skin Tumor Centre and Head of the German Central Malignant Melanoma Registry.

Allan C. Halpern (USA)
  • Chief, Dermatology Service, Memorial Sloan Kettering

  • Cancer Center, New York City

Henry W. Lim (USA)
  • Henry Ford Health

  • Program Director, Dermatology Research, C.S. Livinggood

  • Program Director, Photomedicine Fellowship

  • Specialize in vitiligo, psoriasis, allergic reaction to sunlight (photosensitivity), eczema, and cutaneous T-cell lymphoma (skin cancer)

Josep Malvehy (Spain)
  • Director of the Skin Cancer Unit

  • Consultant of the Dermatology Service of Hospital Clínic. University of Barcelona. Spain

  • Associate professor at the Faculty of Medicine of the University of Barcelona

  • Researcher at the "Institut d'Investigació Biomédica August Pi i Sunyer (IDIBAPS)"

Je-Ho Mun (South Korea)
  • Associate Professor, Department of Dermatology, Seoul National University Hospital

  • Department of Dermatology, Seoul National University College of Medicine

Uli Osterwalder (Switzerland)
  • Sun Protection Facilitator GmbH. Basel, Switzerland

  • Independent scientific and technical advisor in Sun Protection. Chair of ISO TC 217 (Cosmetics).

  • Scientific autor Sun Protection Facilitator GmbH and is committed to contribute to further improvements in sun protection. Uli Osterwalder works for ISO on the development of new UV protection assessment methods and is author and co-author of numerous scientific articles and book chapters on sun protection.

Vishal Patel (USA)
  • Assistant Professor of Dermatology| Director, Cutaneous Oncology Program

  • GW Cancer Center

  • The George Washington University Hospital

Giovanni Pellacani (Italy)
  • Chairman of the Dermatology Clinic and Director of the School of Dermatology of the University La Sapienza, Roma

  • He practices research mainly in the field of cutaneous physiopathology, skin bio-engineering for the evaluation of inflammatory diseases, non-invasive diagnosis in dermato-oncology, since 1995.

Susana Puig Sardá (Spain)
  • Head of the Dermatology Service of the Hospital Clínic de Barcelona

  • Dermatology specialist at barnaclínic

  • Leader of the IDIBAPS "Melanoma: Imaging, Genetics and Immunology" research group

  • Professor at the University of Barcelona

Deborah S. Sarnoff (USA)
  • Clinical professor of dermatology, Ronald O. Perelman

  • Department of Dermatology, NYU School of Medicine

José Antonio Sanches (Brazil)
  • He is a professor at the Faculty of Medicine of the University of São Paulo. He has experience in Medicine, with an emphasis on Clinical Dermatology, working mainly in the area of Cutaneous Oncology, paraneoplasms and skin eruptions caused by antineoplastic agents.

  • Coordinator of the Cutaneous Lymphoma Group at the Hospital das Clínicas, Faculty of Medicine, USP

Sérgio Schalka (Brazil)
  • Coordinator of the Brazilian Consensus on Photoprotection

  • Chairman of the Latin American Photoprotection Alliance

  • USP Associate Researcher

  • Specialist in Photoprotection

  • Managing Partner of Grupo Medcin

Rafael Aron SCHMERLING (Brazil)
  • Medical Oncologist at BP - Beneficência Portuguesa de São Paulo

  • Hospital for the Heart

  • Head of Medical Oncology Division

  • Medical Oncology

  • São Paulo, Brazil

Chrysalyne D. Schmults (USA)
  • Vice Chair, Surgical Oncology, Department of Dermatology Program Director, Micrographic Surgery and Dermatologic Oncology Fellowship Program

  • Associate Professor, Harvard Medical School

Peter Soyer (Australia)
  • Academic dermatologist with over 30 years’ experience in the field. He was appointed as the inaugural Chair in Dermatology by The University of Queensland (UQ) in 2007 and as Director of the Princess Alexandra Hospital (PAH) Dermatology Department in 2008. He has a strong focus on translational skin cancer research in his dual role as Director of the Dermatology Research Centre (DRC), UQ Diamantina Institute, UQ Faculty of Medicine; and leadership of the Dermatology Department at the Princess Alexandra Hospital in Brisbane.

Rolf-Markus Szeimies (Germany)
  • Klinikum Vest GmbH

  • Dermatology & Allergology

  • Head of Department

  • Academic teaching. Ruhr Universität. Bochum

Richard Scolyer (Australia)
  • Royal Prince Alfred Hospital, NSW Health Pathology, Melanoma Institute Australia, The University of Sydney

  • Professor Richard Scolyer AO (BMedSci, MBBS, MD, FRCPA, FRCPath, FAHMS) is the Co-Medical Director of Melanoma Institute Australia; Senior Staff Specialist in Tissue Pathology and Diagnostic Oncology at the Royal Prince Alfred Hospital, NSW Health Pathology; and Conjoint Professor for the Faculty of Medicine and Health at The University of Sydney

MAIN SESSIONS
  • Advanced BCC management

  • Controversies in Skin Cancer

  • Cutaneous lymphoma

  • Cutaneous toxicity of systemic oncologic therapy

  • Dermato-Oncology in Latin America

  • Dermoscopy

  • Dermoscopy Course

  • Ex vivo confocal microscopy in fast evaluation - Mohs surgery

  • Field cancerization

  • First experiences with a Telehealth Network for Melanoma Surveillance in Australia

  • GBM - Grupo Brasileiro de Melanoma

  • Grupo Argentino de Linfomas Cutáneos (GALIC)

  • High risk Squamous Cell Carcinoma

  • How to identify patient with high risk melanoma? and how to manage them?

  • Is pathology the gold standard for melanoma diagnosis? (PRE-RECORDED)

  • Management of high risk early stage melanoma

  • Merkel cell carcinoma and other rare tumors

  • Merkel Cell Carcinoma: Update and challenges

  • Mohs surgery

  • New technologies in Melanoma diagnosis

  • Obstacles in melanoma prevention (why it does not work)

  • Pathogenesis of melanoma: evolution from precursor lesions

  • Photoprotection, skin cancer and cutaneous toxicities (AVENE)

  • Running a Cancer Center

  • Skin Cancer in Latin America

  • Skin cancer in the immunosuppressed patient

  • Skin Cancer Pathology

  • Sociedad de Mohs - LATAM

  • Systemic management of advanced melanoma

  • The future of sunscreens

  • Updates of the WHO classification: how many melanomas subtypes are there?

参会说明

常规注册包括:会议、展览、会议资料、茶歇等

随行人员注册包括:茶歇、进入展区参观

早鸟注册:须于早期注册截止前完成注册及汇款,如汇款晚于截止日期前到达,则不能享受早鸟价

其它:会议接待、预订展位、境外研修、考察培训、海外推广、机票酒店预定、翻译、境外接送机、会后旅行等请联系我们

参会流程:点击立即报名或联系客服,提交需求客服联系参会人沟通->>确定代办业务并签订合同->>付款->>操作代办业务->>顺利出行

支付方式:线上支付(请联系客服)线下支付请前往银行柜台支付您的参会费用

其他信息

汇款账号及注意事项

单位名称:领域国际商务服务(北京)有限公司

银行名称:招行北京青年路支行

银行账号:110923888910803

注意事项:转账汇款时,请务必确认收款信息是否正确,并填写备注说明,确保填写完整参会,参会人姓名+会议简称+款项用途(例:姓名+DDW+注册费)如果您的汇款信息不完整,会导致无法识别该笔汇款出处。如果您进行银行转账,请务必提供银行汇款单作为证明,以便追踪款项,请将汇款单发送至lingyumed@126.com,一旦确认汇款,注册将在24小时内被确认。

如果汇款后3个工作日内未与您确认订单收款,请及时与我们联系!

联系电话:010-57571855

会议报名咨询:010-57571855 18911270084

立即报名
会员登录

还没账号?请立即注册

联系信息

电话:010-57571855, 18911270084

邮箱:lingyumed@126.com

地址:北京市朝阳区朝阳北路101号